BioSpace News Archive

Wilmington, Delaware, United States: A syringe is a medical equipment used to inject or withdraw fluid from the patient’s body.

Wilmington, Delaware, United States: A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures.

Wilmington, Delaware, United States: The pancreas is anatomically so placed that any growth here affects multiple organs like the stomach, gall bladder and intestines.

Wilmington, Delaware, United States: According to Transparency Market Research’s latest report on the global oligonucleotide synthesis market for the historical period 2017–2018 and forecast period 2019–2027, Increasing use of synthesized oligonucleotides in diagnostics and research applications, and Technological advancements in synthetic chemistry are projected to drive the global oligonucleotide synthesis market during the forecast period

BioPorto A/S announced the appointment of Dr. Prasad Devarajan, MD FAAP FASN, as Senior Medical Director effective July 1, 2022.

Yourgene Health plc, a leading international molecular diagnostics group, announces the launch of the LightBench® Detect, the latest addition to its Ranger® Technology instrumentation portfolio at the 26th International Conference on Prenatal Diagnosis and Therapy.

Bausch Health Companies Inc. today announced its presence at the European Association for the Study of the Liver’s (EASL) International Liver Congress™ (ILC) 2022 through the presentation of new XIFAXAN® (rifaximin) data that was selected for inclusion in the program.

XOMA Corporation announced its Board of Directors has authorized the following cash dividends to holders of XOMA’s Series A and Series B Cumulative Preferred Stock.

Akadeum Life Sciences, Inc., a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics, and cell and molecular research for human health and life sciences, announces a patent issuance for its proprietary method of buoyancy-based cell sorting technologies from biological fluid samples.

Ultragenyx’s continued support bolsters n-Lorem’s non-profit model to provide personalized investigational medicines to nano-rare patients.